Johan Fährenmark

Title: The Innovative Contributions of Johan Fährenmark

Introduction

Johan Fährenmark is a notable inventor based in Sollentuna, Sweden. He has made significant contributions to the field of biotechnology, particularly in the purification of chymosin. His innovative methods have implications for various applications in the food and pharmaceutical industries.

Latest Patents

Fährenmark holds a patent for a "Method for the purification of chymosin." This patent describes a process that involves providing an aqueous liquid sample containing chymosin and a separation medium. The separation medium comprises a base matrix and a plurality of firmly attached ligands capable of binding to chymosin. The method includes contacting the matrix with the sample under conditions that allow for the binding of chymosin to the matrix, followed by desorbing chymosin from the matrix. A key feature of this method is that the matrix is hydrophilic, and the ligands consist of hydrocarbon groups where all carbon atoms are sp-hybridized. Additionally, ether oxygen or thioether sulfur may be inserted between carbon atoms, and hydroxy groups may replace hydrogen atoms in the hydrocarbon groups.

Career Highlights

Throughout his career, Johan Fährenmark has worked with prominent companies in the biotechnology sector. Notably, he has been associated with GE Healthcare Bio-Sciences AB and DSM IP Assets B.V. His work in these organizations has contributed to advancements in bioprocessing and enzyme technology.

Collaborations

Fährenmark has collaborated with several professionals in his field, including Inger Lagerlund and Robert Morenweiser. These collaborations have fostered innovation and development in the methods he has pioneered.

Conclusion

Johan Fährenmark's contributions to the purification of chymosin exemplify the impact of innovative thinking in biotechnology. His work continues to influence the industry and pave the way for future advancements.